Tag: Prescription Drugs

But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo

Mixed results seen for effect of siponimod on cognitive processing speed in patients with secondary progressive multiple sclerosis

After CDC guideline publication, there was a 14 percent decrease in oxycodone prescriptions, but not for other Schedule II opioids

Discontinuing asthma medications in pregnancy associated with increased odds of birth at <37 and <32 weeks of gestation

Odds of improvement in clinical status at day 15 greater for baricitinib plus remdesivir versus remdesivir alone

No difference seen in cumulative incidence of hip fracture for continuing therapy for two, five additional years versus discontinuing

Subcutaneous daratumumab plus pomalidomide and dexamethasone reduces risk of progression, death in relapsed/refractory MM

Remdesivir, hydroxychloroquine, lopinavir, interferon regimens have little to no effect on in-hospital mortality

Pembrolizumab superior to chemo for progression-free survival among patients who had not previously received treatment

Risks for fracture, falls, ischemic stroke increased in patients with dementia prescribed higher doses of Z-drugs